JAK-STAT Pathway Heterogeneity Governs Immunotherapy Response in Breast Cancer
Jianbo Zhou, Heng Zhang, Hailin Tang, Lei Yu, Fu Peng
This paper investigates JAK-STAT pathway heterogeneity in breast cancer and finds that high JSP activity correlates with improved immunotherapy response, particularly in triple-negative breast cancer.
eLife · Sep 17, 2026Peer-reviewedCancer Biology